New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 12, 2013
07:46 EDTELOSSyneron Medical reports Q4 adjusted EPS 11c, consensus 9c
Reports Q4 revenue $72.8M, consensus $70.6M.
News For ELOS From The Last 14 Days
Check below for free stories on ELOS the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 17, 2014
12:13 EDTELOSSyneron Medical recommend following FDA clearance at Maxim
Maxim recommends investors continue buying shares of Syneron Medical following the FDA clearance of UltraShape. Maxim says UltraShape expands the base of body shaping treatments that physicians may use with complimentary Syneron systems and it keeps a Buy rating on the stock with a $16 price target.
April 16, 2014
10:55 EDTELOSSyneron Medical to host conference call
Subscribe for More Information
April 14, 2014
09:12 EDTELOSSyneron Medical receives FDA clearance to market UltraShape System
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use